BANU KARACA

Dr. BANU KARACA

Dr
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH
Verified
Journal Article
Closed access
PDF file
BKBANU KARACA
BANU KARACA
Yeni tip Korona virus enfeksiyonun erişkin yaş grubunda klinik bulguları değişkenlik göstermekle birlikte en sık semptomlar ateş, kuru öksürük ve nefes darlığıdır. Bunlara boğaz ağrısı, myalji, başağrısı ve halsizlik eşlik edebilir. Daha nadir olarak anozmi, tat kaybının yanısıra bulantı, ishal gibi gastrointestinal semptomlar da saptanabilir. İleri yaş ve eşlik eden komorbid hastalıkların varlığı klinik tablonun ağırlaşmasında rol oynar. Klinik ARDS’ye ilerleyebilir. Olası ve kesin olgu tanımlarında laboratuvar ve radyolojik verilerin yanında klinik bulgular önem taşır.

22 November 2023 in Angiology
Verified
Journal Article
Closed access
BKBANU KARACA
BANU KARACA
BOBahar Ormen
Bahar Ormen
TKTuncay Kırış
Tuncay Kırış
ASAlper Sener
Alper Sener
Diabetic foot infections are one of the complications of diabetes mellitus resulting in extremity amputation and mortality. This study aimed to examine the predictive value of the C-reactive protein (CRP) to albumin ratio (CAR) for amputation risk in diabetic foot infection. Data from 178 patients were retrospectively examined. We found the cut point value of 15.45 according to the receiver operating characteristic (ROC) curve to show the predictive value of CAR for amputation risk in the overall population. We then divided the patients into two groups low (<15.45, n = 96) and high risk (≥15.45, n = 82) according to their CAR value. Matching based on propensity scores produced 64 patients in each group and showed that the amputation rate was high in the high-risk groups (50 vs 25%, P = .003). In the multivariate analysis in the matching group, previous amputation, antibiotic therapy in the last 3 months, and CAR (Odds ratio [OR]: 1.30, 95%Confidence interval [CI]: 1.01-1.45, P < .001) were independent predictors of amputation. These parameters may be useful to predict amputation risk in these patient groups.

4 January 2014 in Hernia
Verified
Journal Article
Closed access
PDF file
BKBANU KARACA
BANU KARACA
HTH. Tarakci
H. Tarakci
ETE. Tumer
E. Tumer
SCS. Calik
S. Calik
NSN. Sen
N. Sen
OSO. N. Sivrikoz
O. N. Sivrikoz

9 October 2021 in The Egyptian Journal of Otolaryngology
Verified
Journal Article
Open access
PDF file
ABA. F. Bayrak
A. F. Bayrak
BKBANU KARACA
BANU KARACA
YÖY. Özkul
Y. Özkul
Background: It could be of great benefit to determine smell and taste dysfunction in COVID-19 patients and to investigate the relationship between these symptoms and clinical characteristics as the determination of points requiring attention during the clinical course of the disease. Method: Evaluations of patients diagnosed with COVID-19 were made using a questionnaire method. Those with smell and taste dysfunction completed a visual analog scale (VAS) to determine severity. The patients were evaluated at the end of 1 and 2 months. Results: Evaluation was made of a total of 105 patients with a mean age of 55.9±17.6 years. Smell and taste dysfunction was present in 56 (53.3%) patients with a mean age of 48.7±17.6 years and the 49 (46.7%) patients with no smell and taste dysfunction had a mean age of 64±13.6 years. It was determined that as age increased, the complaints of smell and taste dysfunction decreased. Full recovery was determined in 31 (55%) patients after 1 month, and in 16 (28%) patients, smell and taste dysfunction continued at the end of the second month. The symptoms of smell and taste dysfunction were determined to last longer in patients with no comorbidities, no symptoms of fever or shortness of breath, and those treated as outpatients (p=0.043, p=0.031, p=0.034, p=0.028, respectively). In the older age patient group, the VAS scores were observed to be higher and the time to recovery was shorter (p=0.007, p=0.018, respectively). Conclusion: Smell and taste dysfunction in COVID-19 patients is seen more as age decreases and recovery takes longer. Smell and taste dysfunction is seen more in patients with symptoms of cough, nasal obstruction, and headache and lasts longer in patients without symptoms of fever and shortness of breath, with no comorbidities and in those treated as outpatients.

21 January 2023 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
BKBANU KARACA
BANU KARACA
MAMurat Aksun
Murat Aksun
NKNagihan Altıncı Karahan
Nagihan Altıncı Karahan
SGSenem Girgin
Senem Girgin
BOBahar Ormen
Bahar Ormen
ASAtilla Sencan
Atilla Sencan
Objectives: There are limited data about nosocomial coinfections of COVID-19 cases monitored in the intensive care unit. This study aims to investigate coinfections in COVID-19 patients followed in an intensive care unit of a university hospital. Methods: This study analyzed retrospectively the data of coinfections of 351 COVID-19 patients in the period 28.02.2020–15.01.2021 in a tertiary care intensive care unit in a university hospital. Results: Bacterial coinfections were present in 216 of the 351 cases. One hundred and thirty of these cases were evaluated as nosocomial infections. On the third day the Sequential Organ Failure Assessment Score, usage of invasive mechanical ventilation and presence of septic shock were significantly higher in the coinfected group. The neutrophil/lymphocyte ratio, polymorphonuclear leukocyte count, procalcitonin, ferritin, and blood urea nitrogen values were significantly higher in the coinfection group. White blood cells (WBC) (OR: 1.075, 95% CI 1.032–1.121, p = 0.001) and ICU hospitalization day (OR: 1.114, 95% CI 1.063–1.167, p < 0.001) were found to be independent risk factors for coinfection in the multivariate logistic regression analysis. The rates of hospitalization day on the day of arrival, the 21st day, as well as total mortality (p = 0.004), were significantly higher in the coinfected group. Conclusion: Bacterial coinfections of COVID-19 patients in the intensive care unit remain a problem. Identifying the infectious agent, classifying colonizations and infections, and using the proper treatment of antibiotics are of great importance in the case management of COVID-19 patients in the intensive care unit.

12 November 2022 in Angiology
Verified
Journal Article
Closed access
BKBANU KARACA
BANU KARACA
FEFatma Kayaaltı Esin
Fatma Kayaaltı Esin
EÖEmre Özdemir
Emre Özdemir
MTMuhammet Mücahit Tiryaki
Muhammet Mücahit Tiryaki
SÖSelin Özdemir
Selin Özdemir
TKTuncay Kırış
Tuncay Kırış
This study aimed to evaluate the utility of the systemic immune-inflammation index (SII) in predicting the development of Cardiac Implantable Electronic Device (CIED) infections. A retrospective analysis was performed using the medical records of 2185 patients who underwent CIED (including de novo, revision, or upgrade) implantation at our institution from January 2012 to December 2019. We recorded CIED infections and risk factors according to the patient, device, and procedural characteristics during the median 28.7 months (6.2–56.8) follow-up. CIED infections were identified in 52 patients. Diabetes, chronic renal disease, SII before implantation, new cardiac resynchronization therapy (CRT) implantation, CRT-battery replacement, revision or upgrade, and the number of previous procedures were independent predictors of CIED infections. The area under the curve (AUC) of SII to predict CIED infection was .733 (95% CI: .654-.811). A raised SII may be a useful predictor of CIED infection.